Compare COHU & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COHU | BBNX |
|---|---|---|
| Founded | 1947 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | N/A | 2025 |
| Metric | COHU | BBNX |
|---|---|---|
| Price | $24.15 | $29.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $29.33 | $28.09 |
| AVG Volume (30 Days) | ★ 649.2K | 497.1K |
| Earning Date | 10-29-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $424,848,000.00 | $88,570,000.00 |
| Revenue This Year | $14.95 | $52.13 |
| Revenue Next Year | $12.03 | $36.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $12.57 | $8.89 |
| 52 Week High | $29.08 | $32.71 |
| Indicator | COHU | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 58.38 |
| Support Level | $21.14 | $26.13 |
| Resistance Level | $24.40 | $32.71 |
| Average True Range (ATR) | 0.95 | 2.05 |
| MACD | 0.14 | 0.06 |
| Stochastic Oscillator | 87.24 | 49.70 |
Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.